Salidroside and exercise performance in healthy active young adults - an exploratory, randomized, double-blind, placebo-controlled study

被引:0
|
作者
Schwarz, Neil A. [1 ,2 ]
Stratton, Matthew T. [1 ]
Colquhoun, Ryan J. [1 ,2 ]
Manganti, Alexia M. [1 ]
Sherbourne, Margaux [3 ]
Mourey, Florian [3 ]
White, Caitlyn C. [1 ]
Day, Heather [1 ]
Dusseault, Micaela C. [1 ]
Hudson, Geoffrey M. [1 ]
Vickery, Christopher R. [4 ]
Schachner, Holly C. [5 ]
Kasprzyk, Philip G. [5 ]
Weng, Jing-Ke [5 ,6 ,7 ,8 ]
机构
[1] Univ S Alabama, Dept Hlth Kinesiol & Sport, Exercise & Nutr Res Grp ENRG, Mobile, AL 36688 USA
[2] Univ S Alabama, Frederick C Whiddon Coll Med, Dept Physiol & Cell Biol, Mobile, AL USA
[3] Gnosis Lesaffre Lesaffre Grp, Dept Res & Applicat, Marcq En Baroeul, France
[4] Recombia Biosci Lesaffre, Bedford, MA USA
[5] DoubleRainbow Biosci Inc, Cambridge, MA USA
[6] Northeastern Univ, Inst Plant Human Interface, Boston, MA 02120 USA
[7] Northeastern Univ, Dept Chem & Chem Biol, Dept Bioengn, Boston, MA USA
[8] Northeastern Univ, Dept Chem Engn, Boston, MA USA
关键词
Salidroside; rhodiola rosea; adaptogen; high-intensity interval exercise; oxygen consumption; golden root; RHODIOLA-ROSEA L; OXIDATIVE STRESS; EXTRACT SHR-5; KINASE; PROTEIN; AMPK;
D O I
10.1080/15502783.2024.2433744
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BackgroundRhodiola rosea extract is purported to improve physical performance and support resilience to stress. Salidroside is considered to be one of the main constituents responsible for the ergogenic actions of R. rosea. However, R. rosea extract contains relatively little salidroside and cultivation of R. rosea is challenging as it is mainly found in high-altitude, cold regions. Additionally, the R. rosea plant is subject to conservation concerns because of its growing popularity. The purpose of this exploratory study was to evaluate the short-term effects of pure, biosynthetic salidroside supplementation on exercise performance, mood state, and markers of inflammation and muscle damage in healthy active young adults. MethodsFifty participants (30 M, 20F; 21 +/- 4 yrs; 173 +/- 8 cm; 74 +/- 13 kg) were randomly assigned to either salidroside (60 mg/day for 16 days) or placebo supplementation and underwent peak oxygen uptake (VO2 peak), intermittent time-to-exhaustion (TTE), and local muscular endurance assessments, along with mood state evaluations using the Profile of Mood States (POMS). Blood samples were analyzed for erythropoietin, myoglobin, creatine kinase-MM, and C-reactive protein. ResultsSalidroside supplementation enhanced overall percent predicted oxygen uptake during high-intensity intermittent exercise (p < 0.01). An increase in serum myoglobin was observed 24 hours following exercise in the placebo group (p = 0.02) compared with baseline whereas no statistically significant increase was observed for the salidroside group indicating reduced exercise-induced muscle damage. Placebo group experienced a decrease in number of intervals performed during the TTE test (p = 0.03), and a decrease in friendliness (p < 0.01) and an increase in fatigue-inertia (p < 0.01) as reported by POMS. The salidroside group exhibited stable mood states and maintained performance levels during the time-to-exhaustion test. ConclusionSalidroside supplementation may enhance oxygen utilization and mitigate exercise-induced muscle damage and fatigue, warranting further research on its long-term effects and potential as an adaptogen for active individuals.
引用
收藏
页数:28
相关论文
共 50 条
  • [41] Randomized, double-blind, placebo-controlled study of efficacy and safety of secukinumab to treat adults with ichthyoses
    Lefferdink, R. L.
    Chima, M.
    Ibler, E.
    Pavel, A. B.
    Kim, H.
    Wu, B.
    Abu-Zayed, H.
    Rangel, S.
    Wu, J.
    Zumpf, K.
    Jackson, K.
    Choate, K.
    Guttman-Yassky, E.
    Paller, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S74 - S74
  • [42] Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study
    Asplund, R
    Sundberg, B
    Bengtsson, P
    BJU INTERNATIONAL, 1999, 83 (06) : 591 - 595
  • [43] APREMILAST FOR ACTIVE ULCERATIVE COLITIS: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Danese, Silvio
    Neurath, Markus
    Kopon, Adam
    Zakko, Salam F.
    Simmons, Timothy C.
    Fogel, Ronald P.
    Maccarone, Judy
    Zhan, Xiaojiang
    Usiskin, Keith
    Chitkara, Denesh
    GASTROENTEROLOGY, 2018, 154 (06) : S167 - S167
  • [44] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
    Taslimi, Shervin
    Vahidi, Hamed
    Pourvaziri, Ali
    Modabbernia, Amirhossein
    Fallah, Arezoo Yeke
    Yazdani, Nasrin
    Taslimi, Negin
    Hosseini, Mostafa
    Zarandi, Masoud Motesadi
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (05) : 1635 - 1641
  • [45] BUSERELIN TREATMENT OF CRYPTORCHIDISM - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    BICA, DTG
    HADZISELIMOVIC, F
    JOURNAL OF UROLOGY, 1992, 148 (02): : 617 - 621
  • [46] CIAMEXONE IN ENDOCRINE ORBITOPATHY - A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    KAHALY, G
    LIEB, W
    MULLERFORELL, W
    MAINBERGER, M
    BEYER, J
    VOLLMAR, J
    STAIGER, C
    ACTA ENDOCRINOLOGICA, 1990, 122 (01): : 13 - 21
  • [47] Augmenting Clozapine With Sertindole A Double-Blind, Randomized, Placebo-Controlled Study
    Nielsen, Jimmi
    Emborg, Charlotte
    Gydesen, Susanne
    Dybbro, Jesper
    Aagaard, Jorgen
    Haderup, Karsten
    Glyngdal, Pia
    Fabricius, Susanne
    Thode, Dorrit
    Lublin, Henrik
    Andersen, Torben
    Damkier, Per
    Taylor, David
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (02) : 173 - 178
  • [48] Randomized, Placebo-Controlled, Double-Blind Study of Ropinirole in Chronic Stroke
    Cramer, Steven C.
    Dobkin, Bruce H.
    Noser, Elizabeth A.
    Rodriguez, Rachelle W.
    Enney, Lori A.
    STROKE, 2009, 40 (09) : 3034 - 3038
  • [49] Kratom and Pain Tolerance: A Randomized Placebo-Controlled, Double-Blind Study
    Vicknasingam, Balasingam
    Chooi, Weng Tink
    Rahim, Azlan Abdul
    Ramachandram, Dinesh
    Singh, Darshan
    Ramanathan, Surash
    Yusof, Nur Sabrina Mohd
    Zainal, Hadzliana
    Murugaiyah, Vikneswaran
    Gueorguieva, Ralitza
    Mansor, Sharif Mahsufi
    Chawarski, Marek C.
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 2020, 93 (02): : 229 - 238
  • [50] A randomized, double-blind, placebo-controlled study of lorazepam as premedication for bronchoscopy
    Maltais, F
    Laberge, F
    Laviolette, M
    CHEST, 1996, 109 (05) : 1195 - 1198